 | |
| Company type | Private |
|---|---|
| Industry | Venture capital |
| Founded | 1999 |
| Headquarters | One Sansome Street, San Francisco, California, U.S. |
Key people | Brad Bolzon (Chairman) |
| AUM | US$4.2 billion (2023) |
| Website | www |
| Footnotes / references [1] | |
Versant Ventures ("Versant") is an American Venture capital firm headquartered in San Francisco, California. It is focused on making investments in the healthcare and biotechnology industries.
Background
In 1999 at the end of the Dot-com bubble, several partners from Brentwood Associates joined with partners from Institutional Venture Partners and Crosspoint Ventures to create two separate industry-focused firms, Redpoint Ventures which focused on technology and Palladium Venture Capital which focused on healthcare. Palladium Venture Capital was later renamed to Versant Ventures. Versant was established in Menlo Park.[2][3][4][5][6][7]
After its establishment, Versant raised $250 million for its first fund, Versant Venture Capital I.[4][6]
In the mid-2000s, Versant launched EuroVentures, a business incubator based in Basel, Switzerland that formed startup companies by acquiring assets from European drug companies.[8]
In 2011, Versant launched Inception, an incubator based in San Diego that would help create companies using discoveries from academia.[8]
In 2013, Inception expanded into Canada and opened offices in Vancouver and Montreal. Versant also launched another incubator named Blueline Bioscience in Toronto.[8][9]
In 2015, Versant launched Highline Therapeutics, an incubator based in New York that would launch drug companies out of medical research centers in the state.[9]
In 2017, Versant set up another incubator in Basel named Ridgeline that would help give entrepreneurs access to scientists and wet labs.[10]
Versant invests in companies based in the United States, Canada and Europe. It deploys half its funds towards outside companies and half to developing companies in-house.[2][7][8]
Versant is headquartered in San francisco with additional offices in Basel, New York, San Diego, Toronto and Vancouver.[7][8][9]
References
- ^ "Form ADV" (PDF). SEC. Archived (PDF) from the original on May 26, 2023. Retrieved May 26, 2023.
- ^ a b Reisinger, Jenny (January 27, 2003). "Funding With Versant Ventures". Wall Street Journal. ISSN 0099-9660. Archived from the original on May 26, 2023. Retrieved May 26, 2023.
- ^ "Redpoint Ventures on making successful tech investments - Aug. 29, 2000". money.cnn.com. Archived from the original on May 26, 2023. Retrieved May 26, 2023.
- ^ a b "Palladium, Redpoint Round Up First Funds - | Venture Capital Journal". July 30, 2021. Archived from the original on July 30, 2021. Retrieved May 26, 2023.
- ^ Lee, Chong-Moon (2000). The Silicon Valley Edge: A Habitat for Innovation and Entrepreneurship. Stanford University Press. ISBN 978-0-8047-4063-0. Archived from the original on May 26, 2023. Retrieved May 26, 2023.
- ^ a b Smagalla, David (September 2009). "In PEA's Pages A Decade Ago". The Private Equity Analyst. ProQuest 197100166.
- ^ a b c Mack, Heather. "Biotech Firm Versant Ventures Raises Largest Fund to Date at $700 Million". WSJ. Archived from the original on May 26, 2023. Retrieved May 26, 2023.
- ^ a b c d e Gormley, Brian (April 5, 2013). "Versant Ventures Expands Biotech Incubator to Canada". Wall Street Journal. ISSN 0099-9660. Archived from the original on May 26, 2023. Retrieved May 26, 2023.
- ^ a b c Gormley, Brian (August 24, 2015). "Versant Launches NYC Biotech Incubator Highline Therapeutics". Wall Street Journal. ISSN 0099-9660. Archived from the original on May 26, 2023. Retrieved May 26, 2023.
- ^ Paul Taylor, Nick (March 10, 2020). "Versant plots Basel expansion as incubator hits full capacity". Fierce Biotech. Archived from the original on May 26, 2023. Retrieved May 26, 2023.
External links
This page was last edited on 16 March 2024, at 03:34